Molecular Spring Constant Analysis by Biomembrane Force Probe Spectroscopy
November 20th, 2021
A biomembrane force probe (BFP) is an in situ dynamic force spectroscopy (DFS) technique. BFP can be used to measure the spring constant of molecular interactions on living cells. This protocol presents spring constant analysis for molecular bonds detected by BFP.
This video describes step-by-step procedures on using Biomembrane Force Probe, or BFP to measure molecular spring constant. In force probe, BFP has recently emerged in the native cell surface or in SITU Dynamic Force Spectroscopy analysis. The main aim of this technique is to measure single molecule binding genetics.
This data analysis procedure is a simple but powerful message and provide mechanical information, specifically the dynamic force and inflammation of the cell membrane expressing molecules. During the BFP experiment cycle, the probe microbiome bet with the red blood cell and probate, the target cell and the ligand receptor molecular bonding between the probe and the target can be considered as a series connected brain system. Based on Hooke's law, the reciprocal of the total spring constant of a series connected spring system is equal to the sum of the inverse spring constant of each single component, as the equation shows.
The spring constant of red blood cell is calculated based on events motion, which is dependent to the radial of the probe micropipette in the orifice. The red blood cell, the circular contact area between the red blood cell and the probate and the micro-pipette aspirating pression. The BFP road data is obtained by a homemade left view virtual instrument, which controls the movement of the target micro-pipette by a PAs Translator.
A full PFP touch cycle consists of five stages.Approach.Impinge.Contact. Retract and dissociate. In the beginning, does stress the Robusto APICS position is denoted as X equals 0 in black deshine.
The target is then driven by a piece or translator to impinge on and compress the robusto to cause negative probate movement. You note it as X smaller than zero in red dash line. In the retract stage, the red busto apex move from the X smaller than zero position back to the X equal to zero position referred to as the compressive phase.
If a bond is formed between the ligand receptor molecule complex, the red blood cell would further different to other positive direction. This X greater than zero period is referred to as the tensile phase of the retract stage. The retract stage is the most critical part to determine the spring constant of the molecule of bonding.
Collect force versus time road data using the BSP data acquisition platform. Each experiments usually record 50 to 200 touch cycles, Open the PFP data analysis software. Click on the yellow folder icon and select the corresponding row data file by double clicking on them.
We're on the program. Then click on the up and down arrow buttons to switch between events. Using the outlier exclusion criteria to screen out invalid events.
Select the exporting data type that's forced to time format and choose the appropriate state range of time. Click on the export plot data button. The exported data is saved as text file in default.
This text file contains two columns of data. It's the first column representing the time daddies and the second column representing the corresponding force at each time point. Plot the force versus time curve using spreadsheets software to obtain the forced versus displacement curve.
Multiply the time value of each data point by the Willow Steel PSO movement. Zero the first data point by subtracting the smallest displacement value from each data point. This horizontal transformation does not affect the subsequent spring constant calculation.
In the force versus displacement curve, two distinct actor group was different if the new force slope can be identified. Each representing the compressive phase and the 10 style phase. Fit a regression line to each data group.
The line with steeper slope represents the total spring constant at a compressor phase denoted as K1.And the line that was smallest top represents the line at this 10 style phase denoted as K2.As I've mentioned, the total spring constant is the reciprocal of the son of the series spring constant of each component. During the compressive phase of the beat to cell mode, the molecular bonding is not stretched, therefore the molecular bonding spring constant is not taken into consideration. The spring constant of the target cell is described as the equation displayed where K1 represents the total spring constant during the compressor phase.
In the 10 style phase of the beat to sell mode, the total spring constant is the sun of the uverse spring constant of the red blood cell molecular bond. And the target cell, use the equation displayed to calculate the moleculer bonding spring constant, which K2 represents the total spring constant. You read the 10 stop phase.
In the beat to beat mode, since B deformation is negligible, the term which describes the inverse of the target cell spring constant approach zero, therefore the total spring constant in the compressor phase is equivalent to the red blood cell spring constant showing as the following equation. In the tensile phase, the spring constant of the molecular bonding can be calculated by subtracting the effect of the red blood cell showing as the following equation. Collect spring constants of the side-wind integrating attitude B, Beta 3 complex, the K562 cell and the Febrifugine integrating attitude B Beta three complex, calculate the mean and standard deviation of the derived spring constants at pick a Newton or nanometers scale.
Now you should have a better understanding of what are the requirements for measuring and spring constant out of the VFD data. The differences between the beat to cell mode and the beat to beat mode should be noticed. Different molecule presenting service will have different defenses to the measure of spring constant.
In conclusion, this step-by-step procedure describes how to perform molecular spring constant analysis using BFP. We foresee future efforts will be made to automate and integrate the BFP data acquisition and DFS analysis into one computer rest program. Making the entire BFP operation data analysis more user friendly and high throughout.
View the full transcript and gain access to thousands of scientific videos
Overview
The Biomembrane Force Probe (BFP) is a dynamic force spectroscopy technique used to measure the spring constant of molecular interactions on living cells. This protocol outlines the analysis of spring constants for molecular bonds detected by BFP.
Key Study Components
Area of Science
- Dynamic force spectroscopy
- Molecular interactions
- Cell membrane mechanics
Background
- The BFP technique measures single molecule binding.
- It provides mechanical information about cell membranes.
- The analysis is based on Hooke's law.
- It involves interactions between probes and target cells.
Purpose of Study
- To measure molecular spring constants.
- To analyze molecular bonding dynamics.
- To enhance understanding of cell membrane interactions.
Methods Used
- Use of Biomembrane Force Probe (BFP).
- In situ dynamic force spectroscopy analysis.
- Data analysis of molecular interactions.
- Application of Hooke's law for spring constant calculation.
Main Results
- Successful measurement of molecular spring constants.
- Insights into the dynamics of molecular bonding.
- Demonstration of BFP's effectiveness in live cell analysis.
- Validation of theoretical models through experimental data.
Conclusions
- BFP is a powerful tool for studying molecular interactions.
- The technique enhances our understanding of cell mechanics.
- Future applications may include broader biological studies.
Frequently Asked Questions
Executive Industry Relevance
Measuring molecular spring constants via biomembrane force probe spectroscopy provides quantitative mechanical insights into ligand-receptor interactions, supporting target validation by characterizing bond stability and conformational dynamics. This approach enables mechanistic de-risking in early discovery by linking molecular mechanics to functional signaling, informing go/no-go decisions before compound screening. The method enhances predictive confidence in target selection by revealing force-dependent binding behaviors that correlate with physiological mechanosensing pathways.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by quantifying bond stiffness and rupture forces under physiological loading rates.
- Operational Value: Enables direct comparison of molecular variants or mutants to identify stabilizing mutations that prolong bond lifetime.
- Scientific Value: Clarifies force-dependent conformational changes in receptors, supporting allosteric mechanism validation.
- Operational Value: Provides benchmark data for structure-guided design of therapeutics with optimized mechanical resilience.
Screening & Assay Development
- Scientific Value: Generates force-displacement curves that serve as orthogonal readouts for binding affinity in assay triage.
- Operational Value: Standardizes spring constant measurements across replicates using outlier exclusion criteria and regression fitting.
- Scientific Value: Distinguishes specific from nonspecific interactions based on tensile phase slope characteristics in bead-bead mode.
- Operational Value: Enables high-throughput collection of 50-200 touch cycles per experiment for robust statistical analysis.
Translational & Preclinical Research
- Scientific Value: Connects molecular spring constants to cellular mechanosensing outputs, informing pathophysiological relevance in disease models.
- Operational Value: Supports continuity from purified systems to native cell surfaces via bead-cell and bead-bead modes.
- Scientific Value: Measures cell contribution to total spring constant, deconvolving target-specific molecular mechanics from probe or cell artifacts.
- Operational Value: Facilitates cross-platform comparison of molecular mechanics using standardized Hooke's law-based analysis.
Pipeline & Workflow Integration
The method integrates into early discovery workflows by providing mechanical phenotyping of targets after initial binding confirmation but before large-scale screening, helping prioritize targets with favorable force-stability profiles.
- Discovery Biology: Tests target hypothesis by measuring how molecular bonds respond to mechanical perturbation, revealing catch-bond or slip-bond behavior.
- Screening: Delivers quantitative, reproducible spring constant outputs that enable rank-ordering of ligand variants or therapeutic candidates.
- Analytics: Employs linear regression on force-displacement data to derive spring constants (K1, K2) from compressive and tensile phases, enabling condition comparison.
- Translational Research: Links molecular mechanics to cell-scale responses by measuring target cell contribution in bead-cell mode, supporting mechanistic continuity.
- Enterprise Reuse: Establishes a reusable nanotool for mechanical phenotyping across diverse receptor-ligand systems, reducing revalidation effort in follow-up campaigns.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity by providing direct, quantitative measures of bond elasticity and force-dependent kinetics.
- Operational Value: Ensures reproducibility through standardized data acquisition, outlier filtering, and exportable force-time datasets for external validation.
- Strategic Value: Improves go/no-go decisions by identifying mechanically fragile targets early, reducing investment in high-risk pathways.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on bond stability metrics, complementing traditional affinity and selectivity data.
Implementation Considerations
- Requires expertise in dynamic force spectroscopy, micropipette manipulation, and force calibration using red blood cell standards.
- Depends on custom-built BFP setup with piezoelectric translators and homemade virtual instrumentation for precise displacement control.
- Necessitates cross-team standardization of outlier criteria, time-range selection, and regression fitting protocols across sites.
- Involves adaptation considerations when transitioning from bead-cell to bead-bead mode to isolate molecular contributions from cellular mechanics.
- Limited by the need for stable molecular tethering and functional ligand-receptor expression on probe or target surfaces to avoid artifactual signals.
